Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab in Non-Infectious Uveitis (SATURN)
NCT01900431Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of sarilumab in noninfectious uveitis (NIU), sponsored by Sanofi. Started Oct 2013; status: completed.
02
Drugs
sarilumab
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT01900431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01900431.